During brain vascularization, canonical Wnt/β-catenin signaling in endothelial cells (ECs) was shown in 2018 to be dispensable for sprout invasion but essential for capillary anastomosis—the fusion of sprouts into a connected network—because it counteracts sphingosine-1-phosphate receptor-1 (S1pr1)-dependent Rac1 activation that otherwise removes VE-cadherin and Esama from nascent cell–cell junctions. The epistasis chain (Wnt inhibition → S1pr1- and Rac1-dependent loss of junctional VE-cadherin/Esama → anastomosis and lumen defects, rescued by S1pr1 or Rac1 blockade) is established, but the mechanism is not: the Wnt-dependent effector(s) that suppress S1pr1 signaling during the angiogenic window, the post-transcriptional trafficking or scaffolding process underlying junctional protein loss, the basis of the developmental switch that makes neonatal but not adult brain ECs sensitive to Wnt inhibition, and whether the Wnt–S1pr1–Rac1 module operates beyond zebrafish central-artery angiogenesis all remain unidentified. Adjacent progress—mammalian confirmation of Wnt-dependent postnatal CNS angiogenesis, a Wnt effector (Mmp25) for basement-membrane invasion, and a context-reversed Wnt–S1P coupling in vascular smooth muscle—leaves every facet of the antagonism mechanism unresolved.

Background

The vertebrate brain is vascularized by endothelial sprouts that invade the neural parenchyma, connect tip-to-tip in a process called anastomosis, form a lumen, and only then mature into capillaries sealed by the blood–brain barrier (BBB), the selective barrier property of CNS vessels. Canonical Wnt/β-catenin signaling—in which Wnt ligands such as Wnt7a/b stabilize β-catenin so it enters the nucleus and activates TCF/LEF target genes—is a master regulator of CNS vascularization and BBB induction; in brain ECs it acts through a dedicated Gpr124/Reck co-receptor complex. VE-cadherin (Cdh5) is the endothelial-specific adherens-junction adhesion molecule whose homophilic binding cements cell–cell junctions, and Esama is its junctional partner of the ESAM immunoglobulin-superfamily; both are required for efficient vessel fusion. Sphingosine-1-phosphate (S1p) is a blood-borne bioactive lipid that signals through G protein-coupled S1p receptors (S1pr1–5); S1pr1 promotes endothelial junction integrity and vascular stabilization in mature vessels, in part by activating the small GTPase Rac1. Prior to 2018, S1p signaling had been tied to BBB maintenance and vascular maturation, but not to brain capillary angiogenesis. Hübner et al. (Nat Commun 9:4860, 2018), using temporally and spatially restricted Wnt manipulation with in vivo time-lapse imaging in zebrafish hindbrain central arteries (CtAs) plus mouse primary brain EC cultures, established that Wnt signaling is continuously active in CtAs, is dispensable for sprout invasion and filopodia formation, yet is required for anastomosis: inhibiting endothelial Wnt signaling (dominant-negative Tcf, or the tankyrase inhibitor IWR-1) reduced junctional VE-cadherin, Esama, and ZO-1 without lowering their transcripts (so the effect is post-transcriptional), caused anastomosis and lumen defects, and led to S1pr1-dependent Rac1 overactivation. Crucially, S1pr1 blockade (VPC23019), s1pr1 knockdown, or endothelial S1pr1 knockout rescued both junctional VE-cadherin and vessel morphology under Wnt inhibition, as did Rac1 inhibition. The authors therefore proposed that Wnt signaling suppresses S1pr1–Gαi–Rac1 signaling during the angiogenic window so that dynamic junctions can form, whereas after lumenization Wnt activity drops and blood-derived S1p is permitted to stabilize junctions for BBB maturation—identifying Wnt as the coordinator of the timing of angiogenesis versus barriergenesis. In mouse brain ECs this regulation is developmentally staged: ECs isolated from postnatal day 3 (P3) brains lose junctional VE-cadherin under IWR-1, while adult brain ECs are insensitive. The paper's Discussion leaves open how the antagonism works: proteasomal degradation, lysosomal degradation, and internalization were excluded by inhibitor series as sole causes of the junctional protein loss; the Wnt-dependent effector(s) interfering with S1pr1 signaling (at the level of G-protein coupling, second-messenger generation, or Rac1 guanine nucleotide exchange factor regulation) is unknown; the molecular basis of the neonatal-to-adult responsiveness switch is unexplained; the module's operation in other Wnt-dependent contexts (mammalian brain angiogenesis, pharyngeal pouch formation, pathological neovascularization) is untested; and how Wnt- or S1p-directed therapeutic interventions (e.g., the FDA-approved S1p-receptor modulator fingolimod/FTY720, or Wnt-pathway drugs in oncology and neurodegeneration) affect angiogenesis versus barriergenesis in developing or diseased CNS tissue remains unpredictable.

Problem Statement

Determine the molecular mechanism by which canonical Wnt/β-catenin signaling in endothelial cells counteracts S1pr1-dependent signaling to permit VE-cadherin- and Esama-mediated anastomosis of brain capillaries, as established in zebrafish central-artery angiogenesis by Hübner et al. (2018), by resolving four separately open sub-questions: (1) the locus of antagonism—identify the Wnt-dependent effector(s) and the level at which they act (S1pr1–Gαi protein coupling, second-messenger generation, or regulation of the Rac1 guanine nucleotide exchange factors that drive Rac1 overactivation when Wnt signaling is inhibited during the angiogenic window); (2) the post-transcriptional mechanism—define the trafficking, scaffolding, or cytoskeletal-coupling process whose failure removes VE-cadherin and Esama from nascent cell–cell junctions upon Wnt inhibition, noting that proteasomal degradation, lysosomal degradation, and dynamin-dependent internalization have been excluded experimentally as sole causes and that the transcripts are not Wnt-regulated; (3) the developmental switch—explain at the molecular level why immature (postnatal day 3) brain endothelial cells lose junctional VE-cadherin under Wnt inhibition while adult brain endothelial cells are insensitive; and (4) the scope of the module—establish whether the Wnt–S1pr1–Rac1 regulatory module operates in other Wnt-dependent morphogenetic and pathological contexts; mammalian brain angiogenesis, pharyngeal pouch formation, and CNS pathological neovascularization are illustrative, independently testable examples rather than an exhaustive or conjunctive requirement, so establishing the module in any one of them resolves whether it is confined to zebrafish central-artery angiogenesis. Predicting how therapeutic manipulation of Wnt or S1p pathways (e.g., Wnt-pathway drugs or the S1p-receptor modulator fingolimod) affects angiogenesis versus barriergenesis in developing or diseased CNS tissue is a translational implication that follows if these sub-questions are answered, not a separately required deliverable.

References

  1. Hübner K, Cabochette P, Diéguez-Hurtado R, Wiesner C, Wakayama Y, Grassme KS, Hubert M, Guenther S, Belting H-G, Affolter M, Adams RH, Vanhollebeke B, Herzog W. Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nature Communications 9:4860 (2018). doi:10.1038/s41467-018-07302-x, https://doi.org/10.1038/s41467-018-07302-x
  2. Garnier O, Vilgrain I. Dialogue between VE-Cadherin and Sphingosine 1 Phosphate Receptor1 (S1PR1) for Protecting Endothelial Functions. International Journal of Molecular Sciences 24:4018 (2023). doi:10.3390/ijms24044018, https://doi.org/10.3390/ijms24044018
  3. Oliveira-Paula GH, Liu S, Maira A, Ressa G, Ferreira GC, Quintar A, Jayakumar S, Almonte VM, Parikh D, Valenta T, Basler K, Hla T, Riascos-Bernal DF, Sibinga NES. The β-catenin C terminus links Wnt and sphingosine-1-phosphate signaling pathways to promote vascular remodeling and atherosclerosis. Science Advances 10:eadg9278 (2024). doi:10.1126/sciadv.adg9278, https://doi.org/10.1126/sciadv.adg9278
  4. Schevenels G, Cabochette P, America M, Vandenborne A, De Grande L, Guenther S, He L, Dieu M, Christou B, Vermeersch M, Germano RFV, Perez-Morga D, Renard P, Martin M, Vanlandewijck L, Betsholtz C, Vanhollebeke B. A brain-specific angiogenic mechanism enabled by tip cell specialization. Nature 628:863–871 (2024). doi:10.1038/s41586-024-07283-6, https://doi.org/10.1038/s41586-024-07283-6
  5. Martowicz A, Trusohamn M, Jensen N, Wisniewska-Kruk J, Corada M, Ning FC, Kele J, Dejana E, Nyqvist D. Endothelial β-Catenin Signaling Supports Postnatal Brain and Retinal Angiogenesis by Promoting Sprouting, Tip Cell Formation, and VEGFR (Vascular Endothelial Growth Factor Receptor) 2 Expression. Arteriosclerosis, Thrombosis, and Vascular Biology 39:2273–2288 (2019). doi:10.1161/ATVBAHA.119.312749, https://doi.org/10.1161/ATVBAHA.119.312749
  6. Garnier O, Jeanneret F, Durand A, Fertin A, Berndt S, Carpentier G, Battail C, Martin DK, Vilgrain I. Efficient Fine-Tuning of Endothelial Gene Expression by a Single Tyrosine (Y685) to Phenylalanine Point Mutation in the VE-Cadherin Gene. Arteriosclerosis, Thrombosis, and Vascular Biology 45:1852–1871 (2025). doi:10.1161/ATVBAHA.125.323129, https://doi.org/10.1161/ATVBAHA.125.323129 (PMID: 40808655)
  7. Li G, Zhang H, Liu M, Liu Y-j, Shen S, Li S, Zhu W. The S1PR1–CCN1 axis drives endothelial-to-mesenchymal transition and vascular instability in brain arteriovenous malformations. European Journal of Medical Research 30:1175 (2025). doi:10.1186/s40001-025-03484-5, https://doi.org/10.1186/s40001-025-03484-5
  8. Le TNU, Nguyen TQ, Kalailingam P, Nguyen YTM, Sukumar VK, Tan CKH, Tukijan F, Couty L, Hasan Z, Del Gaudio I, Wenk MR, Cazenave-Gassiot A, Camerer E, Nguyen LN. Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and in anaphylactic shock. Cell Reports 40:111208 (2022). doi:10.1016/j.celrep.2022.111208, https://doi.org/10.1016/j.celrep.2022.111208
  9. Choe CP, Collazo A, Trinh LA, Pan L, Moens CB, Crump JG. Wnt-dependent epithelial transitions drive pharyngeal pouch formation. Developmental Cell 24:296–309 (2013). doi:10.1016/j.devcel.2012.12.003, https://doi.org/10.1016/j.devcel.2012.12.003
  10. Yanagida K, Liu CH, Faraco G, Galvani S, Smith HK, Burg N, Anrather J, Sanchez T, Iadecola C, Hla T. Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Proceedings of the National Academy of Sciences USA 114:4531–4536 (2017). doi:10.1073/pnas.1618659114, https://doi.org/10.1073/pnas.1618659114
  11. Gaengel K, Niaudet C, Hagikura K, Laviña B, Muhl L, Hofmann JJ, Ebarasi L, Nyström S, Rymo S, Chen LL, Pang M-F, Jin Y, Raschperger E, Roswall P, Schulte D, Benedito R, Larsson J, Hellström M, Fuxe J, Uhlén P, Adams R, Jakobsson L, Majumdar A, Vestweber D, Uv A, Betsholtz C. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Developmental Cell 23:587–599 (2012). doi:10.1016/j.devcel.2012.08.005, https://doi.org/10.1016/j.devcel.2012.08.005
  12. Vanhollebeke B, Stone OA, Bostaille N, Cho C, Zhou Y, Maquet E, Gauquier A, Cabochette P, Fukuhara S, Mochizuki N, Nathans J, Stainier DYR. Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/beta-catenin pathway during brain angiogenesis. eLife 4:e06489 (2015). doi:10.7554/eLife.06489, https://doi.org/10.7554/eLife.06489
  13. Tran KA, Zhang X, Predescu D, Huang X, Machado RF, Göthert JR, Malik AB, Valyi-Nagy T, Zhao Y-Y. Endothelial beta-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis. Circulation 133:177–186 (2016). doi:10.1161/CIRCULATIONAHA.115.015982, https://doi.org/10.1161/CIRCULATIONAHA.115.015982